Insights

Innovative Focus REMED specializes in regenerative medicine research, positioning it as a forward-looking organization committed to advancing innovative healthcare solutions. This focus on cutting-edge therapies suggests potential interest in technologies that enhance research capabilities or clinical trial management.

Growth Potential With a small revenue range of up to one million dollars and a growing trend in regenerative medicine, REMED may be seeking strategic partnerships, funding opportunities, or technology integrations to expand its research scope and commercial impact.

Digital Engagement The company's utilization of a comprehensive tech stack including Google Analytics and Tag Manager indicates an active online presence, offering sales teams opportunities to propose digital tools or data analytics solutions to improve outreach, research dissemination, or stakeholder engagement.

Alignment with Peers Positioned alongside similarly sized entities in neurorehabilitation and research, REMED presents opportunities for collaborative projects, shared research initiatives, or equipment and service offerings that cater to niche clinical and research applications.

Regional Opportunity Based in Tehran and operating within Iran, REMED offers a potential gateway for businesses looking to expand into Middle Eastern markets, providing localized partnerships, regulatory insights, or tailored solutions aligned with regional healthcare development goals.

REMED Tech Stack

REMED uses 8 technology products and services including Open Graph, PHP, reCAPTCHA, and more. Explore REMED's tech stack below.

  • Open Graph
    Content Management System
  • PHP
    Programming Languages
  • reCAPTCHA
    Security
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics
  • X-UA-Compatible
    Web Tools And Plugins
  • jQuery custom content scroller
    Web Tools And Plugins

Media & News

REMED's Email Address Formats

REMED uses at least 2 format(s):
REMED Email FormatsExamplePercentage
FLast@remed.comJDoe@remed.com
91%
First.Last@remed.comJohn.Doe@remed.com
8%
LastF@remed.comDoeJ@remed.com
1%

Frequently Asked Questions

Where is REMED's headquarters located?

Minus sign iconPlus sign icon
REMED's main headquarters is located at Tehran 5173867681 Iran. The company has employees across 4 continents, including AsiaNorth AmericaEurope.

What is REMED's stock symbol?

Minus sign iconPlus sign icon
REMED is a publicly traded company; the company's stock symbol is REMEDY.HE.

What is REMED's official website and social media links?

Minus sign iconPlus sign icon
REMED's official website is usern.tums.ac.ir and has social profiles on LinkedIn.

What is REMED's NAICS code?

Minus sign iconPlus sign icon
REMED's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does REMED have currently?

Minus sign iconPlus sign icon
As of March 2026, REMED has approximately 58 employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Chief Executive Officer: C. R.Vice President Of Operations: E. S.Founder: R. R.. Explore REMED's employee directory with LeadIQ.

What industry does REMED belong to?

Minus sign iconPlus sign icon
REMED operates in the Research Services industry.

What technology does REMED use?

Minus sign iconPlus sign icon
REMED's tech stack includes Open GraphPHPreCAPTCHAGoogle Tag ManagerBootstrapGoogle AnalyticsX-UA-CompatiblejQuery custom content scroller.

What is REMED's email format?

Minus sign iconPlus sign icon
REMED's email format typically follows the pattern of FLast@remed.com. Find more REMED email formats with LeadIQ.

When was REMED founded?

Minus sign iconPlus sign icon
REMED was founded in 2020.

REMED

Research ServicesTehrān, Iran51-200 Employees

Regenerative medicine holds the promise to restitute the normal function of cells, tissues or organs lost due to disease or damage via replacing or regenerating. An up-ward progressive trend of regenerative medicine acts as a precursor in order to translate promising technologies from the bench top to the clinic.

Section iconCompany Overview

Headquarters
Tehran 5173867681 Iran
Stock Symbol
REMEDY.HE
NAICS Code
5417 - Scientific Research and Development Services
Founded
2020
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    REMED's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    REMED's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.